EDRN Prostate & Urogenital Cancers Collaborative Group Meeting

Chair: (Virtual) John Semmes, PhD, Eastern Virginia Medical School

Co-chair: (In-person) Jeff Tosoian, MD, Vanderbilt University Medical Center

NCI Program Directors: (In-person) Indu Kohaar, PhD and (In-person) Richard Mazurchuk, PhD, National Cancer Institute


8:00 a.m. – 10:00 a.m.	Progress Reports by Earlier Funded Sites Presentations will highlight progress, proposed collaborative projects, and future directions
8:00 a.m. – 8:20 a.m.	01: Michigan-VUMC Biomarker Characterization Center (In-person) Jeffrey J Tosoian, MD, MPH Vanderbilt University Medical Center (In-person) Arul M Chinnaiyan, MD, PhD University of Michigan
8:20 a.m. – 8:30 a.m.	Q&A
8:30 a.m. – 8:50 a.m.	02: Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern (In-person) Martin G. Sanda, MD, Emory University
8:50 a.m. – 9:00 a.m.	Q&A
9:00 a.m. – 9:20 a.m.	03: NCI EDRN MRI Biomarker Study and Reference Set (PMRI) (Virtual) John T. Wei, MD, MS, University of Michigan
9:20 a.m. – 9:30 a.m.	Q&A
9:30 a.m. – 9:50 a.m.	04: BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs (In-person) Daniel W. Chan, PhD, Johns Hopkins University
9:50 a.m. – 10:00 a.m.	Q&A
10:00 a.m.	Adjourn